Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2003
07/10/2003WO2002018577A9 48921, a novel human gtp releasing factor and uses therefor
07/10/2003WO2002016596A3 pRNA CHIMERA
07/10/2003WO2002013845A3 Inflammation related g-protein coupled receptor
07/10/2003WO2002012281A3 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
07/10/2003WO2001096559A3 Regulatable, catalytically active nucleic acids
07/10/2003WO2001089550A3 Use of ciliary neurotrophic factor
07/10/2003WO2001089549A3 Therapeutic uses of il-1 receptor antagonist
07/10/2003US20030131380 Coffee mannanase
07/10/2003US20030131369 Metabotropic glutamate receptor 4B (mGluR4) disruptions, compositions and methods relating thereto
07/10/2003US20030131366 Non-human mammals comprising cells expressing vector-borne mouse PTTG carboxy-terminal-related DNA
07/10/2003US20030131363 Controlling the activation of genetic translation, cell proliferation, especially hematopoietic cells; drug screening for compounds which alter the activity of the kinase; thalassemias, sickle cell disease, unstable hemoglobins
07/10/2003US20030130496 Immunoglobulins; cloning, amplifying and encoding by DNA sequences, polymerase chain reaction
07/10/2003US20030130495 G-protein coupled receptors, signal transduction pathways
07/10/2003US20030130494 Mammalian chemokine reagents
07/10/2003US20030130493 Endothelial Differentiation Gene (Edg), neuroregulators, phospholipid metabolism, nervous systems
07/10/2003US20030130491 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130490 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins; extracellular
07/10/2003US20030130489 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins
07/10/2003US20030130487 Acellular red blood cell substitute
07/10/2003US20030130486 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects
07/10/2003US20030130485 Novel human genes and methods of use thereof
07/10/2003US20030130484 A peptides for treating amyloid fibrils; drug screening for potential antagonist; antifibrillatory agents
07/10/2003US20030130483 Amino acid sequences free of signal peptide, encoded by cDNA; fusion proteins
07/10/2003US20030130324 Method for preventing or controlling cataract
07/10/2003US20030130323 Anorectic agents
07/10/2003US20030130297 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
07/10/2003US20030130272 Topoisomerase inhibitor; viricides
07/10/2003US20030130270 Heterocyclic derivatives and their use as antithrombotic agents
07/10/2003US20030130256 Stimulant of central nervous system regeneration
07/10/2003US20030130250 Methods to mobilize progenitor/stem cells
07/10/2003US20030130223 Gene therapy composition for treating arthritis
07/10/2003US20030130222 Apoptosis; modulate gene expression; central nervous system disorders; anticancer agents; Aids therapy
07/10/2003US20030130221 Induction of tolerance to a therapeutic polypeptide
07/10/2003US20030130219 Classification of genes; medical diagnosis
07/10/2003US20030130218 Methods of stimulating phagocytosis
07/10/2003US20030130216 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease(cad) for treating cardiac disease
07/10/2003US20030130215 Isolated genomic polynucleotide fragments from chromosome 7
07/10/2003US20030130214 Proteins, compositions, diagnostic and therapeutic uses thereof
07/10/2003US20030130209 Method of treatment of myocardial infarction
07/10/2003US20030130204 Antipicornaviral compounds and compositons, their pharmaceutical uses, and materials for their synthesis
07/10/2003US20030130202 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
07/10/2003US20030130200 Tripeptide or tetrapeptide
07/10/2003US20030130199 Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
07/10/2003US20030130197 Neuroprotective peptides
07/10/2003US20030130196 Administering angiotensin; antitumor agents; side effect reduction
07/10/2003US20030130195 Enzymatic hydrolysate of milk proteins
07/10/2003US20030130193 Controlling cell proliferation, cell differentiation; immobilization
07/10/2003US20030130192 Administration of leptin
07/10/2003US20030130191 Mutant polypeptide; side effect reduction
07/10/2003US20030130186 Conjugates and compositions for cellular delivery
07/10/2003US20030130185 Metal-binding compounds and uses therefor
07/10/2003US20030130184 Using protein from papilloma virus; genetic engineering
07/10/2003US20030130183 Adjust permeability of skin membrane; topical applying urogenital system
07/10/2003US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130181 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130177 Antilipemic agents
07/10/2003US20030130176 Spary drying dispersion; antiinflammatory agents; antihistamines; lung diseases
07/10/2003US20030130174 Antiinflammatory agents; rheumatic diseases; anticholesterol agents
07/10/2003US20030130173 Bactericides for drug resistant bacteria
07/10/2003US20030130172 Novel lipoglycopeptide antibiotics
07/10/2003US20030130169 Methods of treating drug-resistant bacterial infections
07/10/2003US20030130168 Reverse-turn mimetics and methods relating thereto
07/10/2003US20030129750 Inducing vascular growth in tissue via administration of cytokine, chemokine, or chemoattractant; for treatment of cardiac ischemia; tissue engineering
07/10/2003US20030129725 Zace1: a human metalloenzyme
07/10/2003US20030129722 Comprises phospholipid scramblase phosphorylated by protein kinases; antithrombotic agents
07/10/2003US20030129706 Fhm, a novel member of the TNF ligand supergene family
07/10/2003US20030129703 Modified dorsal tissue affecting factor and compositions
07/10/2003US20030129702 DNA encoding galanin GALR2 receptors and uses thereof
07/10/2003US20030129701 Detecting a mutation in the RAR epsilon receptor nucleic acid sequences and detecting a level of the soluble form of the receptors
07/10/2003US20030129698 Involved in homo and heterotrimerization or oligomerization
07/10/2003US20030129697 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis
07/10/2003US20030129696 Polynucleotides and polypeptides encoding receptors
07/10/2003US20030129695 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129694 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129693 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129692 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129690 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129689 Nucleotide sequence that encodes a PRO polypeptide.
07/10/2003US20030129688 Heregulin variants
07/10/2003US20030129687 Keratinocyte growth factor-2
07/10/2003US20030129685 12 human secreted proteins
07/10/2003US20030129678 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
07/10/2003US20030129675 Assaying the ability of a compound to block the binding of an alpha 4 integrin to a binding partner thereof
07/10/2003US20030129655 Nucleic acids encoding GTPase activating proteins
07/10/2003US20030129653 Treating aberrant cell growth, endocrine conditions, neurological conditions, and diseases or disorders related to the pituitary gland, colon, breast, lungs, and prostate
07/10/2003US20030129650 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129645 Can be used as models for the development of human therapeutic targets, aid in the identification of therapeutic proteins, and serve as targets for the development of human therapeutic agents that modulate kinase activity
07/10/2003US20030129644 Used in gene therapy
07/10/2003US20030129643 T1 receptor-like ligand I
07/10/2003US20030129638 Reagents for antagonizing the protein-protein interaction between Raf-1 and apoptosis signal-regulating kinase and uses therefor
07/10/2003US20030129631 Three of three sets of RT-PCR-amplified transcripts from prostatic adenocarcinomas display multiple cancer-associated coding sequence changes; normal pp32 exerts antineoplastic effects through suppression of transformation.
07/10/2003US20030129628 Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease
07/10/2003US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
07/10/2003US20030129597 Inhibiting EG-1 to inhibit angiogenesis and metastasis
07/10/2003US20030129592 Identification and characterization of extracellular polypeptides having homology to EGF
07/10/2003US20030129587 Antigen/antibody specificity exchanger
07/10/2003US20030129586 Contains amino acid motifs of a serine proteinase, a nucleotide triphosphatase (NTPase), and an RNA helicase.
07/10/2003US20030129582 Method for determining early HCV seroconversion
07/10/2003US20030129577 Especially serine proteinases comprising a first and second kunitz domain and can further comprise a C-terminal domain.
07/10/2003US20030129262 Methionine restriction for cancer therapy
1 ... 1813 1814 1815 1816 1817 1818 1819 1820 1821 1822 1823 1824 1825 1826 1827 1828 1829 1830 1831 1832 1833 ... 3163